Global Benidipine Market Size, Share, and COVID-19 Impact Analysis, By Dosage Form (Capsules, Tablets, and Others), By Indications (Angina Pectoris, Hypertension, and Others), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare
RELEASE DATE Apr 2025
REPORT ID SI9437
PAGES 240
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Dosage Form
      2. Market Attractiveness Analysis By Indications
      3. Market Attractiveness Analysis By Distribution Channel
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increasing prevalence of angina pectoris
    3. Restraints
      1.  High cost of branded benidipine drugs
    4. Opportunities
      1.  Advancements in the formulation of benidipine
    5. Challenges
      1. Stringent regulatory requirements
  6. Global Benidipine Market Analysis and Projection, By Dosage Form
    1. Segment Overview
    2. Capsules
    3. Tablets
    4. Others
  7. Global Benidipine Market Analysis and Projection, By Indications
    1. Segment Overview
    2. Angina Pectoris
    3. Hypertension
    4. Others
  8. Global Benidipine Market Analysis and Projection, By Distribution Channel
    1. Segment Overview
    2. Retail Pharmacies
    3. Online Pharmacies
    4. Hospital Pharmacies
    5. Others
  9. Global Benidipine Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Benidipine Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Benidipine Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Lupin Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Mylan N.V. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Torrent Pharmaceuticals Ltd. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   GlaxoSmithKline plc 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Sun Pharmaceutical Industries Ltd. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   AstraZeneca plc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Takeda Pharmaceutical Company Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Johnson and Johnson
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  AbbVie Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Bayer AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Kyowa Kirin Co., Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Tables

  1. Global Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  2. Global Capsules, Benidipine Market, By Region, 2024-2034(USD Billion)
  3. Global Tablets, Benidipine Market, By Region, 2024-2034(USD Billion)
  4. Global Others, Benidipine Market, By Region, 2024-2034(USD Billion)
  5. Global Benidipine Market, By Indications, 2024-2034(USD Billion)
  6. Global Angina Pectoris, Benidipine Market, By Region, 2024-2034(USD Billion)
  7. Global Hypertension, Benidipine Market, By Region, 2024-2034(USD Billion)
  8. Global Others, Benidipine Market, By Region, 2024-2034(USD Billion)
  9. Global Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  10. Global Retail Pharmacies, Benidipine Market, By Region, 2024-2034(USD Billion)
  11. Global Online Pharmacies, Benidipine Market, By Region, 2024-2034(USD Billion)
  12. Global Hospital Pharmacies, Benidipine Market, By Region, 2024-2034(USD Billion)
  13. Global Others, Benidipine Market, By Region, 2024-2034(USD Billion)
  14. North America Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  15. North America Benidipine Market, By Indications, 2024-2034(USD Billion)
  16. North America Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  17. U.S.  Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  18. U.S.  Benidipine Market, By Indications, 2024-2034(USD Billion)
  19. U.S.  Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  20. Canada Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  21. Canada Benidipine Market, By Indications, 2024-2034(USD Billion)
  22. Canada Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  23. Mexico Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  24. Mexico Benidipine Market, By Indications, 2024-2034(USD Billion)
  25. Mexico Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  26. Europe Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  27. Europe Benidipine Market, By Indications, 2024-2034(USD Billion)
  28. Europe Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  29. Germany Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  30. Germany Benidipine Market, By Indications, 2024-2034(USD Billion)
  31. Germany Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  32. France Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  33. France Benidipine Market, By Indications, 2024-2034(USD Billion)
  34. France Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  35. U.K.  Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  36. U.K.  Benidipine Market, By Indications, 2024-2034(USD Billion)
  37. U.K.  Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  38. Italy Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  39. Italy Benidipine Market, By Indications, 2024-2034(USD Billion)
  40. Italy Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  41. Spain Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  42. Spain Benidipine Market, By Indications, 2024-2034(USD Billion)
  43. Spain Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  44. Asia Pacific Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  45. Asia Pacific Benidipine Market, By Indications, 2024-2034(USD Billion)
  46. Asia Pacific Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  47. Japan Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  48. Japan Benidipine Market, By Indications, 2024-2034(USD Billion)
  49. Japan Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  50. China Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  51. China Benidipine Market, By Indications, 2024-2034(USD Billion)
  52. China Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  53. India Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  54. India Benidipine Market, By Indications, 2024-2034(USD Billion)
  55. India Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  56. South America Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  57. South America Benidipine Market, By Indications, 2024-2034(USD Billion)
  58. South America Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  59. Brazil Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  60. Brazil Benidipine Market, By Indications, 2024-2034(USD Billion)
  61. Brazil Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  62. The Middle East and Africa Benidipine Market, By Dosage Form, 2024-2034(USD   Billion)
  63. The Middle East and Africa Benidipine Market, By Indications, 2024-2034(USD   Billion)
  64. The Middle East and Africa Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  65. UAE Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  66. UAE Benidipine Market, By Indications, 2024-2034(USD Billion)
  67. UAE Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)
  68. South Africa Benidipine Market, By Dosage Form, 2024-2034(USD Billion)
  69. South Africa Benidipine Market, By Indications, 2024-2034(USD Billion)
  70. South Africa Benidipine Market, By Distribution Channel, 2024-2034(USD Billion)

 

List of Figures 

  1. Global Benidipine Market Segmentation
  2. Benidipine Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Benidipine Market
  9. Top Winning Strategies, 2024-2034
  10. Top Winning Strategies, By Development, 2024-2034(%)
  11. Top Winning Strategies, By Company, 2024-2034
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Benidipine Market
  20. Benidipine Market Segmentation, By Dosage Form
  21. Benidipine Market For Capsules, By Region, 2024-2034 ($ Billion)
  22.  Benidipine Market For Tablets, By Region, 2024-2034 ($ Billion)
  23. Benidipine Market For Others, By Region, 2024-2034 ($ Billion)
  24.  Benidipine Market Segmentation, By Indications
  25.  Benidipine Market For Angina Pectoris, By Region, 2024-2034 ($ Billion)
  26.  Benidipine Market For Hypertension, By Region, 2024-2034 ($ Billion)
  27. Benidipine Market For Others, By Region, 2024-2034 ($ Billion)
  28. Benidipine Market Segmentation, By Distribution Channel
  29. Benidipine Market For Retail Pharmacies, By Region, 2024-2034 ($ Billion)
  30. Benidipine Market For Online Pharmacies, By Region, 2024-2034 ($ Billion)
  31. Benidipine Market For Hospital Pharmacies, By Region, 2024-2034 ($ Billion)
  32. Benidipine Market For Others, By Region, 2024-2034 ($ Billion)
  33. Lupin Limited: Net Sales, 2024-2034 ($ Billion)
  34. Lupin Limited: Revenue Share, By Segment, 2024 (%)
  35. Lupin Limited: Revenue Share, By Region, 2024 (%)
  36. Mylan N.V.: Net Sales, 2024-2034 ($ Billion)
  37. Mylan N.V.: Revenue Share, By Segment, 2024 (%)
  38. Mylan N.V.: Revenue Share, By Region, 2024 (%)
  39. Torrent Pharmaceuticals Ltd.: Net Sales, 2024-2034 ($ Billion)
  40. Torrent Pharmaceuticals Ltd.: Revenue Share, By Segment, 2024 (%)
  41. Torrent Pharmaceuticals Ltd.: Revenue Share, By Region, 2024 (%)
  42. GlaxoSmithKline plc: Net Sales, 2024-2034 ($ Billion)
  43. GlaxoSmithKline plc: Revenue Share, By Segment, 2024 (%)
  44. GlaxoSmithKline plc: Revenue Share, By Region, 2024 (%)
  45. Sun Pharmaceutical Industries Ltd.: Net Sales, 2024-2034 ($ Billion)
  46. Sun Pharmaceutical Industries Ltd.: Revenue Share, By Segment, 2024 (%)
  47. Sun Pharmaceutical Industries Ltd.: Revenue Share, By Region, 2024 (%)
  48. Novartis AG: Net Sales, 2024-2034 ($ Billion)
  49. Novartis AG: Revenue Share, By Segment, 2024 (%)
  50. Novartis AG: Revenue Share, By Region, 2024 (%)
  51. AstraZeneca plc: Net Sales, 2024-2034 ($ Billion)
  52. AstraZeneca plc: Revenue Share, By Segment, 2024 (%)
  53. AstraZeneca plc: Revenue Share, By Region, 2024 (%)
  54. Takeda Pharmaceutical Company Limited: Net Sales, 2024-2034 ($ Billion)
  55. Takeda Pharmaceutical Company Limited: Revenue Share, By Segment, 2024 (%)
  56. Takeda Pharmaceutical Company Limited: Revenue Share, By Region, 2024 (%)
  57. Johnson and Johnson.: Net Sales, 2024-2034 ($ Billion)
  58. Johnson and Johnson.: Revenue Share, By Segment, 2024 (%)
  59. Johnson and Johnson.: Revenue Share, By Region, 2024 (%)
  60. AbbVie Inc.: Net Sales, 2024-2034 ($ Billion)
  61. AbbVie Inc.: Revenue Share, By Segment, 2024 (%)
  62. AbbVie Inc.: Revenue Share, By Region, 2024 (%)
  63. Bayer AG: Net Sales, 2024-2034 ($ Billion)
  64. Bayer AG: Revenue Share, By Segment, 2024 (%)
  65. Bayer AG: Revenue Share, By Region, 2024 (%)
  66. Kyowa Kirin Co., Ltd.: Net Sales, 2024-2034 ($ Billion)
  67. Kyowa Kirin Co., Ltd.: Revenue Share, By Segment, 2024 (%)
  68. Kyowa Kirin Co., Ltd.: Revenue Share, By Region, 2024 (%)
  69. Others: Net Sales, 2024-2034 ($ Billion)
  70. Others: Revenue Share, By Segment, 2024 (%)
  71. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:120
Pages:240
Countries covered:17
Companies covered::20
Forecast CAGR:5.43%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies